PDC*line Pharma is hiring! We have an open position for a Senior/Principal Scientist. Are you interested to join an international dynamic team in the biotech cancer vaccine space? Be part of the...

Jobs

We are very pleased to announce the publication in OncoImmunology of the results of the first in-human trial with our innovative plasmacytoid dendritic cell line based cancer vaccine in melanoma...

Press releases

New article and interview of our President & CEO Eric Halioua for the 2020 edition of the Belgium Healthcare & Life Science Review of the magazine PharmaBoardroom. He introduces the Belgian immuno...

In the press

Liège, Belgium and Grenoble, France, March 3, 2020 – PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, announces today...

Press releases

Liège, Belgium and Grenoble, France, January 22, 2020 – PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, announces...

Press releases

The PDC*line Pharma management team will be present in full force in San Francisco during the JP Morgan Conference 2020! Meet our President & CEO Eric Halioua and our COO Laurent Levy from Sunday Jan...

Events

Today, a new article has been published in the newspaper l'Echos with an interview of our President & CEO Eric Halioua .The article underlines the achievements made by PDC*line Pharma over the last 4...

In the press

PDC*line Pharma is hiring! We have an open position for a Senior/Principal Scientist. Are you interested to join an international dynamic team in the biotech cancer vaccine space? Be part of the...

Jobs

Our President & CEO Eric Halioua will make a company presentation at the Belgium-Korea Pharma-Bio Partnering on the 13th November 2019 in Brussels. This seminar organized by Korea Trade-Investment...

Forum

Thursday, our President & CEO Eric Halioua, will make a company presentation and be chairman of a session on “Therapeutic Vaccines and Oncolytics” at the World Immunotherapy Congress taking place in...

Forum